Skip to main content
. 2020 Jan 1;17(2):161–169. doi: 10.7150/ijms.39444

Figure 3.

Figure 3

Plasma Pl-CSA content was higher in cancer patients than in healthy controls. (A) The plasma pl-CSA content was significantly higher in patients with oesophageal cancer, ovarian cancer, cervical cancer or lung cancer than in healthy controls. (B) ROC curve analysis of plasma pl-CSA for differentiating oesophageal cancer patients from healthy controls. (C) Sensitivity and specificity of plasma pl-CSA content for distinguishing lung cancer patients from healthy controls.